JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soderstrom, H
Right arrow Articles by Forsman, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soderstrom, H
Right arrow Articles by Forsman, A
Journal of Neurology Neurosurgery and Psychiatry 2003;74:918-921
© 2003 BMJ Publishing Group


PAPER

New evidence for an association between the CSF HVA:5-HIAA ratio and psychopathic traits

H Soderstrom1, K Blennow2, A-K Sjodin1, A Forsman

1 Institute of Clinical Neuroscience, Department of Psychiatry, Gothenburg University, and Department of Forensic Psychiatry, Gothenburg, Sweden
2 Institute of Clinical Neuroscience, Department of Neurology and Neurochemistry, Gothenburg University, Sweden

Correspondence to:
Correspondence to:
Dr H Soderstrom, Department of Forensic Psychiatry, Box 4024, 422 04 Hisings Backa, Sweden;
henrik.soderstrom{at}rmv.se

Objectives: To replicate the relation between the CSF HVA:5-HIAA ratio and psychopathic traits previously reported in a pilot group of 22 perpetrators of violent crimes.

Methods: CSF monoamine metabolite concentrations in another 28 violent and sexual offenders, aged 45 or below, referred to pretrial forensic psychiatric investigation, were compared to features of psychopathy according to the Psychopathy Checklist–Revised (PCL-R).

Results: Our previous finding was repeated in the new study group, where the HVA:5-HIAA ratio was strongly associated with psychopathic traits (r = 0.50, p = 0.010), particularly its behavioural aspects (r = 0.523, p = 0.004). In subsamples of individuals from both study groups who had no medication (n = 25) or no current axis I disorder, including a history of mood disorder or substance dependence (n = 21), the HVA:5-HIAA ratio remained strongly associated with all psychopathy factors but most closely with the behavioural features. Retrospective assessments of childhood disruptive symptomatology, such as attention deficit hyperactivity disorder or conduct disorder, analysed in relation to the monoamine metabolites, showed the same association with the HVA:5-HIAA ratio.

Conclusions: Violent and aggressive behavioural traits with childhood onset and adult expression as psychopathic features are associated with changed activity in the brain dopaminergic system, possibly as a result of serotonergic dysregulation.


Keywords: monoamine; catecholamine; violence; PCL-R; ADHD; conduct disorder

Abbreviations: 5-HIAA, 5-hydroxyindoleacetic acid; ADHD, attention deficit-hyperactivity disorder; CD, conduct disorder; CSF, cerebrospinal fluid; HVA, homovanillic acid; MHPG, 3-methoxy-4-hydroxyphenylglycol; PCL-R, Psychopathy Checklist Revised




This article has been cited by other articles:


Home page
AssessmentHome page
D. M. Bolt, R. D. Hare, and C. S. Neumann
Score Metric Equivalence of the Psychopathy Checklist-Revised (PCL-R) Across Criminal Offenders in North America and the United Kingdom: A Critique of Cooke, Michie, Hart, and Clark (2005) and New Analyses
Assessment, March 1, 2007; 14(1): 44 - 56.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S Engelborghs, E Vloeberghs, K Maertens, B Marescau, and P P De Deyn
Evidence for an association between the CSF HVA:5-HIAA ratio and aggressiveness in frontotemporal dementia but not in Alzheimer's disease
J. Neurol. Neurosurg. Psychiatry, July 1, 2004; 75(7): 1080 - 1080.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 by the BMJ Publishing Group Ltd.